FDAnews
www.fdanews.com/articles/81702-gentium-completes-10-9-million-private-placement

GENTIUM COMPLETES $10.9 MILLION PRIVATE PLACEMENT

October 17, 2005

Gentium S.p.A. announced today that it has completed its previously announced $10.9 million private placement of 1,551,125 of its American Depository Shares (ADSs) at a price of $7.05 per ADS. Subject to shareholder approval, investors in the financing will also receive warrants to purchase 620,452 ADSs at an exercise price of $9.69 per ADS. The purchase price is subject to reduction of 20% if the Company's shareholders do not approve the issuance of the warrants within 180 days. Funds managed by Great Point Partners, LLC were the lead investors in the transaction. Rodman & Renshaw LLC acted as the lead placement agent for the offering, and Maxim Group LLC and I-Bankers Securities Incorporated were co-placement agents.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1079797XSL_NEWSML_TO_NEWSML_WEB.xml)